Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marcos A. Espinal is active.

Publication


Featured researches published by Marcos A. Espinal.


Philosophical Transactions of the Royal Society B | 2013

Progress towards eliminating canine rabies: policies and perspectives from Latin America and the Caribbean

Marco Vigilato; Alfonso Clavijo; Terezinha Knöbl; Hugo Marcelo Tamayo Silva; Ottorino Cosivi; Maria Cristina Schneider; Luis Fernando Leanes; Albino Belotto; Marcos A. Espinal

Human rabies transmitted by dogs is considered a neglected disease that can be eliminated in Latin America and the Caribbean (LAC) by 2015. The aim of this paper is to discuss canine rabies policies and projections for LAC regarding current strategies for achieving this target and to critically review the political, economic and geographical factors related to the successful elimination of this deadly disease in the context of the difficulties and challenges of the region. The strong political and technical commitment to control rabies in LAC in the 1980s, started with the regional programme coordinated by the Pan American Health Organization. National and subnational programmes involve a range of strategies including mass canine vaccination with more than 51 million doses of canine vaccine produced annually, pre- and post-exposure prophylaxis, improvements in disease diagnosis and intensive surveillance. Rabies incidence in LAC has dramatically declined over the last few decades, with laboratory confirmed dog rabies cases decreasing from approximately 25 000 in 1980 to less than 300 in 2010. Dog-transmitted human rabies cases also decreased from 350 to less than 10 during the same period. Several countries have been declared free of human cases of dog-transmitted rabies, and from the 35 countries in the Americas, there is now only notification of human rabies transmitted by dogs in seven countries (Bolivia, Peru, Honduras, Haiti, Dominican Republic, Guatemala and some states in north and northeast Brazil). Here, we emphasize the importance of the political commitment in the final progression towards disease elimination. The availability of strategies for rabies control, the experience of most countries in the region and the historical ties of solidarity between countries with the support of the scientific community are evidence to affirm that the elimination of dog-transmitted rabies can be achieved in the short term. The final efforts to confront the remaining obstacles, like achieving and sustaining high vaccination coverage in communities that are most impoverished or in remote locations, are faced by countries that struggle to allocate sufficient financial and human resources for rabies control. Continent-wide cooperation is therefore required in the final efforts to secure the free status of remaining countries in the Americas, which is key to the regional elimination of human rabies transmitted by dogs.


Heart | 2012

Cardiovascular disease mortality in the Americas: current trends and disparities

Maria de Fátima Marinho de Souza; Vilma Pinheiro Gawryszewski; Pedro Ordunez; Antonio Sanhueza; Marcos A. Espinal

Objective To describe the current situation and trends in mortality due to cardiovascular disease (CVD) in the Americas and explore their association with economic indicators. Design and Setting This time series study analysed mortality data from 21 countries in the region of the Americas from 2000 to the latest available year. Main Outcomes Measures Age-adjusted death rates, annual variation in death rates. Regression analysis was used to estimate the annual variation and the association between age-adjusted rates and country income. Results Currently, CVD comprised 33.7% of all deaths in the Americas. Rates were higher in Guyana (292/100 000), Trinidad and Tobago (289/100 000) and Venezuela (246/100 000), and lower in Canada (108/100 000), Puerto Rico (121/100 000) and Chile (125/100 000). Male rates were higher than female rates in all countries. The trend analysis showed that CVD death rates in the Americas declined −19% overall (−20% among women and −18% among men). Most countries had a significant annual decline, except Guatemala, Guyana, Suriname, Paraguay and Panama. The largest annual declines were observed in Canada (−4.8%), the USA (−3.9%) and Puerto Rico (−3.6%). Minor declines were in Mexico (−0.8%) and Cuba (−1.1%). Compared with high-income countries the difference between the median of death rates in lower middle-income countries was 56.7% higher and between upper middle-income countries was 20.6% higher. Conclusions CVD death rates have been decreasing in most countries in the Americas. Considerable disparities still remain in the current rates and trends.


International Journal of Environmental Research and Public Health | 2013

Leptospirosis: A Silent Epidemic Disease

Maria Cristina Schneider; Michel Jancloes; Daniel Forsin Buss; Sylvain Aldighieri; Eric Bertherat; Patricia Najera; Deise I. Galan; Kara N. Durski; Marcos A. Espinal

This special issue of International Journal of Environmental Research and Public Health is dedicated to leptospirosis, an endemic zoonotic disease that is a cause of many acute undifferentiated fevers, especially in tropical countries. While it can be debated whether leptospirosis is an emerging disease, it is evident that it is becoming an emerging public health problem. It is recognized as a disease of epidemic potential that has a significant health impact in many parts of the world.


PLOS Neglected Tropical Diseases | 2014

Where does human plague still persist in Latin America

Maria Cristina Schneider; Patricia Nájera; Sylvain Aldighieri; Deise I. Galan; Eric Bertherat; Alfonso Ruiz; Elsy Maria Dumit; Jean Marc Gabastou; Marcos A. Espinal

Background Plague is an epidemic-prone disease with a potential impact on public health, international trade, and tourism. It may emerge and re-emerge after decades of epidemiological silence. Today, in Latin America, human cases and foci are present in Bolivia, Brazil, Ecuador, and Peru. Aims The objective of this study is to identify where cases of human plague still persist in Latin America and map areas that may be at risk for emergence or re-emergence. This analysis will provide evidence-based information for countries to prioritize areas for intervention. Methods Evidence of the presence of plague was demonstrated using existing official information from WHO, PAHO, and Ministries of Health. A geo-referenced database was created to map the historical presence of plague by country between the first registered case in 1899 and 2012. Areas where plague still persists were mapped at the second level of the political/administrative divisions (counties). Selected demographic, socioeconomic, and environmental variables were described. Results Plague was found to be present for one or more years in 14 out of 25 countries in Latin America (1899–2012). Foci persisted in six countries, two of which have no report of current cases. There is evidence that human cases of plague still persist in 18 counties. Demographic and poverty patterns were observed in 11/18 counties. Four types of biomes are most commonly found. 12/18 have an average altitude higher than 1,300 meters above sea level. Discussion Even though human plague cases are very localized, the risk is present, and unexpected outbreaks could occur. Countries need to make the final push to eliminate plague as a public health problem for the Americas. A further disaggregated risk evaluation is recommended, including identification of foci and possible interactions among areas where plague could emerge or re-emerge. A closer geographical approach and environmental characterization are suggested.


PLOS Neglected Tropical Diseases | 2015

Leptospirosis in Rio Grande do Sul, Brazil: An Ecosystem Approach in the Animal-Human Interface

Maria Cristina Schneider; Patricia Nájera; Martha Maria Pereira; Gustavo Machado; Celso Bittencourt dos Anjos; Rogério Oliveira Rodrigues; Gabriela M Cavagni; Claudia Muñoz-Zanzi; Luis Gustavo Corbellini; Mariana Leone; Daniel Forsin Buss; Sylvain Aldighieri; Marcos A. Espinal

Background Leptospirosis is an epidemic-prone neglected disease that affects humans and animals, mostly in vulnerable populations. The One Health approach is a recommended strategy to identify drivers of the disease and plan for its prevention and control. In that context, the aim of this study was to analyze the distribution of human cases of leptospirosis in the State of Rio Grande do Sul, Brazil, and to explore possible drivers. Additionally, it sought to provide further evidence to support interventions and to identify hypotheses for new research at the human-animal-ecosystem interface. Methodology and findings The risk for human infection was described in relation to environmental, socioeconomic, and livestock variables. This ecological study used aggregated data by municipality (all 496). Data were extracted from secondary, publicly available sources. Thematic maps were constructed and univariate analysis performed for all variables. Negative binomial regression was used for multivariable statistical analysis of leptospirosis cases. An annual average of 428 human cases of leptospirosis was reported in the state from 2008 to 2012. The cumulative incidence in rural populations was eight times higher than in urban populations. Variables significantly associated with leptospirosis cases in the final model were: Parana/Paraiba ecoregion (RR: 2.25; CI95%: 2.03–2.49); Neossolo Litolítico soil (RR: 1.93; CI95%: 1.26–2.96); and, to a lesser extent, the production of tobacco (RR: 1.10; CI95%: 1.09–1.11) and rice (RR: 1.003; CI95%: 1.002–1.04). Conclusion Urban cases were concentrated in the capital and rural cases in a specific ecoregion. The major drivers identified in this study were related to environmental and production processes that are permanent features of the state. This study contributes to the basic knowledge on leptospirosis distribution and drivers in the state and encourages a comprehensive approach to address the disease in the animal-human-ecosystem interface.


PLOS ONE | 2016

Late maternal deaths and deaths from sequelae of obstetric causes in the Americas from 1999 to 2013: A trend analysis

Federico G. de Cosio; Safia S. Jiwani; Antonio Sanhueza; Patricia Soliz; Francisco Becerra-Posada; Marcos A. Espinal

Background Data on maternal deaths occurring after the 42 days postpartum reference time is scarce; the objective of this analysis is to explore the trend and magnitude of late maternal deaths and deaths from sequelae of obstetric causes in the Americas between 1999 and 2013, and to recommend including these deaths in the monitoring of the Sustainable Development Goals (SDGs). Methods Exploratory data analysis enabled analyzing the magnitude and trend of late maternal deaths and deaths from sequelae of obstetric causes for seven countries of the Americas: Argentina, Brazil, Canada, Colombia, Cuba, Mexico and the United States. A Poisson regression model was developed to compare trends of late maternal deaths and deaths from sequelae of obstetric causes between two periods of time: 1999 to 2005 and 2006 to 2013; and to estimate the relative increase of these deaths in the two periods of time. Findings The proportion of late maternal deaths and deaths from sequelae of obstetric causes ranged between 2.40% (CI 0.85% – 5.48%) and 18.68% (CI 17.06% – 20.47%) in the seven countries. The ratio of late maternal deaths and deaths from sequelae of obstetric causes per 100,000 live births has increased by two times in the region of the Americas in the period 2006-2013 compared to the period 1999-2005. The regional relative increase of late maternal death was 2.46 (p<0.0001) times higher in the second period compared to the first. Interpretation Ascertainment of late maternal deaths and deaths from sequelae of obstetric causes has improved in the Americas since the early 2000’s due to improvements in the quality of information and the obstetric transition. Late and obstetric sequelae maternal deaths should be included in the monitoring of the SDGs as well as in the revision of the International Classification of Diseases’ 11th version (ICD-11).


The Lancet | 2012

WHO's relationship with the Stop TB Partnership.

Marcos A. Espinal

612 www.thelancet.com Vol 379 February 18, 2012 4 McKinsey & Company. Independent evaluation of the Stop TB Partnership. London: McKinsey & Company, 2008. http://www.stoptb.org/ assets/documents/resources/publications/ achieve_eval/Stop%20TB%20Evaluation%20 Final%20Report_Exhibits_Annexes.pdf (accessed Nov 4, 2011). 5 Stop TB Department. Global tuberculosis control 2011. Geneva: World Health Organization, 2011. http://www.who.int/tb/ publications/global_report/en/index.html (accessed Nov 5, 2011).


Revista Panamericana De Salud Publica-pan American Journal of Public Health | 2015

Social determinants and inequalities in tuberculosis incidence in Latin America and the Caribbean

César V. Munayco; Oscar J. Mújica; Francisco X. León; Mirtha del Granado; Marcos A. Espinal


Revista Panamericana De Salud Publica-pan American Journal of Public Health | 2017

Cystic echinococcosis in South America: a call for action

Carlos F. Pavletic; Edmundo Larrieu; Eduardo Guarnera; Natalia Casas; Pilar Irabedra; Ciro Ferreira; Julio Sayes; Cesar M. Gavidia; Eduardo Caldas; Michael Laurence Zini Lise; Melody Maxwell; Marcos Arezo; Ana Maria Navarro; Marco Vigilato; Ottorino Cosivi; Marcos A. Espinal; Victor J. Del Rio Vilas


Revista Panamericana De Salud Publica-pan American Journal of Public Health | 2018

The Virgin Islands National Information Systems for Health: vision, actions, and lessons learned for advancing the national public health agenda

Irad Potter; Tracia Petersen; Marcelo D'Agostino; Daniel Doane; Patricia Ruiz; Myrna Marti; James Fitzgerald; Amalia Del Riego; Federico G. de Cosio; Marcos A. Espinal

Collaboration


Dive into the Marcos A. Espinal's collaboration.

Top Co-Authors

Avatar

Maria Cristina Schneider

Pan American Health Organization

View shared research outputs
Top Co-Authors

Avatar

Sylvain Aldighieri

Pan American Health Organization

View shared research outputs
Top Co-Authors

Avatar

Antonio Sanhueza

Pan American Health Organization

View shared research outputs
Top Co-Authors

Avatar

Deise I. Galan

Pan American Health Organization

View shared research outputs
Top Co-Authors

Avatar

Federico G. de Cosio

Pan American Health Organization

View shared research outputs
Top Co-Authors

Avatar

Francisco Becerra-Posada

Pan American Health Organization

View shared research outputs
Top Co-Authors

Avatar

Marco Vigilato

Pan American Health Organization

View shared research outputs
Top Co-Authors

Avatar

Ottorino Cosivi

Pan American Health Organization

View shared research outputs
Top Co-Authors

Avatar

Patricia Nájera

Pan American Health Organization

View shared research outputs
Top Co-Authors

Avatar

Eric Bertherat

World Health Organization

View shared research outputs
Researchain Logo
Decentralizing Knowledge